NewAmsterdam Pharma Company
NAMS
$18.75
Share price
1.24%
Change (1 day)
35.97%
Change (1 year)
Categories
NewAmsterdam Pharma Company (NAMS) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $76.66 M
According to NewAmsterdam Pharma Company's latest financial reports the company's total liabilities are $76.66 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
NewAmsterdam Pharma Company - Total liabilities on balance sheet (from 2023 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $58.7 M | 13.18% |
| 2022-12-31 | $51.86 M | 304.88% |
| 2021-12-31 | $12.81 M | -33.88% |
| 2020-12-31 | $19.37 M |